• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos.单壁碳纳米管(SWCNT)递送的MALAT1反义寡核苷酸对体内多发性骨髓瘤细胞生长的抑制作用
J Vis Exp. 2018 Dec 13(142). doi: 10.3791/58598.
2
Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.靶向 MALAT1/PARP1/LIG3 复合物可诱导多发性骨髓瘤中的 DNA 损伤和细胞凋亡。
Leukemia. 2018 Oct;32(10):2250-2262. doi: 10.1038/s41375-018-0104-2. Epub 2018 Mar 22.
3
Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.RNA干扰下调长链非编码RNA MALAT1抑制多发性骨髓瘤细胞增殖并诱导其凋亡
Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1032-1041. doi: 10.1111/1440-1681.12804. Epub 2017 Aug 24.
4
Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.缺氧诱导的非编码RNA分析揭示转移相关肺腺癌转录本1是血管平滑肌细胞增殖的重要调节因子。
Exp Biol Med (Maywood). 2017 Mar;242(5):487-496. doi: 10.1177/1535370216685434. Epub 2017 Jan 5.
5
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.通过 LNA -gapmeR ASO 对 lncRNA MALAT1 进行药物处理可抑制蛋白酶体亚基的基因表达并引发抗多发性骨髓瘤活性。
Leukemia. 2018 Sep;32(9):1948-1957. doi: 10.1038/s41375-018-0067-3. Epub 2018 Feb 22.
6
Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth.长链非编码 RNA MALAT1 调节内皮细胞功能和血管生长。
Circ Res. 2014 Apr 25;114(9):1389-97. doi: 10.1161/CIRCRESAHA.114.303265. Epub 2014 Mar 6.
7
Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke.长链非编码RNA Malat1调节缺血性中风中的脑血管病变。
J Neurosci. 2017 Feb 15;37(7):1797-1806. doi: 10.1523/JNEUROSCI.3389-16.2017. Epub 2017 Jan 16.
8
The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.长链非编码 RNA MALAT1 通过海绵吸附 miR-217 调控胰腺导管腺癌中 KRAS 的表达,起到竞争性内源 RNA 的作用。
Sci Rep. 2017 Jul 12;7(1):5186. doi: 10.1038/s41598-017-05274-4.
9
Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.长链非编码RNA MALAT1的上调与透明细胞肾细胞癌的肿瘤进展及不良预后相关。
Tumour Biol. 2015 Apr;36(4):2947-55. doi: 10.1007/s13277-014-2925-6. Epub 2014 Dec 6.
10
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.Malat1长链非编码RNA缺失后乳腺肿瘤的分化及转移减少。
Genes Dev. 2016 Jan 1;30(1):34-51. doi: 10.1101/gad.270959.115. Epub 2015 Dec 23.

引用本文的文献

1
Regulatory role of the METTL3/MALAT1 axis in multiple myeloma progression.METTL3/MALAT1轴在多发性骨髓瘤进展中的调控作用。
J Bone Oncol. 2025 Jun 12;53:100695. doi: 10.1016/j.jbo.2025.100695. eCollection 2025 Aug.
2
Social and spatial predictors of collective search behaviors.集体搜索行为的社会和空间预测因素。
Sci Rep. 2025 May 30;15(1):19086. doi: 10.1038/s41598-025-02460-7.
3
Verification of Pain-Related Neuromodulation Mechanisms of Calcitonin in Knee Osteoarthritis.降钙素在膝关节骨关节炎中与疼痛相关的神经调节机制的验证
Mol Neurobiol. 2025 Feb 25. doi: 10.1007/s12035-025-04707-w.
4
Exploring macrophage and nerve interaction in endometriosis-associated pain: the inductive role of IL-33.探索子宫内膜异位症相关疼痛中巨噬细胞与神经的相互作用:IL-33的诱导作用
Inflamm Res. 2025 Feb 19;74(1):42. doi: 10.1007/s00011-025-02010-x.
5
Locked Nucleic Acid Oligonucleotides Facilitate RNA•LNA-RNA Triple-Helix Formation and Reduce Levels.锁核酸寡核苷酸促进 RNA•LNA-RNA 三链体形成并降低 水平。
Int J Mol Sci. 2024 Jan 28;25(3):1630. doi: 10.3390/ijms25031630.
6
Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment.非编码RNA:靶向肿瘤微环境的“敌”还是“友”
Noncoding RNA. 2023 Aug 28;9(5):52. doi: 10.3390/ncrna9050052.
7
In vitro and ex vivo anti-myeloma effects of nanocomposite AsS/ZnS/FeO.纳米复合材料 AsS/ZnS/FeO 的体外和离体抗骨髓瘤效应。
Sci Rep. 2022 Oct 26;12(1):17961. doi: 10.1038/s41598-022-22672-5.
8
Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.基于可逆固定在碳纳米粒子上的 crRNA 的光活化型纳米 CRISPR/Cas9 系统。
Int J Mol Sci. 2021 Oct 9;22(20):10919. doi: 10.3390/ijms222010919.
9
tRNA-like leader-trailer interaction promotes 3'-end maturation of MALAT1.tRNA 样的前导-尾随相互作用促进 MALAT1 的 3'-端成熟。
RNA. 2021 Oct;27(10):1140-1147. doi: 10.1261/rna.078810.121. Epub 2021 Jul 12.
10
Recent Advances in Nanotherapeutics for Multiple Myeloma.多发性骨髓瘤纳米治疗的最新进展
Cancers (Basel). 2020 Oct 27;12(11):3144. doi: 10.3390/cancers12113144.

本文引用的文献

1
Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.靶向 MALAT1/PARP1/LIG3 复合物可诱导多发性骨髓瘤中的 DNA 损伤和细胞凋亡。
Leukemia. 2018 Oct;32(10):2250-2262. doi: 10.1038/s41375-018-0104-2. Epub 2018 Mar 22.
2
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.通过 LNA -gapmeR ASO 对 lncRNA MALAT1 进行药物处理可抑制蛋白酶体亚基的基因表达并引发抗多发性骨髓瘤活性。
Leukemia. 2018 Sep;32(9):1948-1957. doi: 10.1038/s41375-018-0067-3. Epub 2018 Feb 22.
3
Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.长链非编码RNA MALAT1是一种与多发性骨髓瘤髓外播散及不良预后相关的诱导性应激反应基因。
Br J Haematol. 2017 Nov;179(3):449-460. doi: 10.1111/bjh.14882. Epub 2017 Aug 2.
4
FDA Approval of Eteplirsen for Muscular Dystrophy.美国食品药品监督管理局批准依替膦森用于治疗肌肉萎缩症。
JAMA. 2017 Apr 11;317(14):1480. doi: 10.1001/jama.2017.2601.
5
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides.美国食品药品监督管理局批准诺西那生用于治疗脊髓性肌萎缩症,使2016年成为剪接调节寡核苷酸之年。
Nucleic Acid Ther. 2017 Apr;27(2):67-69. doi: 10.1089/nat.2017.0665. Epub 2017 Feb 21.
6
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.多发性骨髓瘤中的表观遗传修饰:DNA和组蛋白甲基化作用的最新进展
Expert Opin Ther Targets. 2017 Jan;21(1):91-101. doi: 10.1080/14728222.2016.1266339.
7
The bright side of dark matter: lncRNAs in cancer.暗物质的光明面:癌症中的长链非编码RNA
J Clin Invest. 2016 Aug 1;126(8):2775-82. doi: 10.1172/JCI84421.
8
Emerging concepts of epigenetic dysregulation in hematological malignancies.血液系统恶性肿瘤中表观遗传失调的新观念
Nat Immunol. 2016 Sep;17(9):1016-24. doi: 10.1038/ni.3517. Epub 2016 Aug 1.
9
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.独特的长链非编码RNA转录指纹图谱可表征多发性骨髓瘤的进展阶段。
Oncotarget. 2016 Mar 22;7(12):14814-30. doi: 10.18632/oncotarget.7442.
10
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.长链非编码RNA的细胞定位对RNA干扰介导的沉默作用的影响大于反义寡核苷酸介导的沉默作用。
Nucleic Acids Res. 2016 Jan 29;44(2):863-77. doi: 10.1093/nar/gkv1206. Epub 2015 Nov 17.

单壁碳纳米管(SWCNT)递送的MALAT1反义寡核苷酸对体内多发性骨髓瘤细胞生长的抑制作用

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos.

作者信息

Lin Jianhong, Hu Yi, Zhao Jian-Jun

机构信息

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic.

出版信息

J Vis Exp. 2018 Dec 13(142). doi: 10.3791/58598.

DOI:10.3791/58598
PMID:30596388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6530462/
Abstract

The single-wall carbon nanotube (SWCNT) is a new type of nanoparticle, which has been used to deliver multiple kinds of drugs into cells, such as proteins, oligonucleotides, and synthetic small-molecule drugs. The SWCNT has customizable dimensions, a large superficial area, and can flexibly bind with drugs through different modifications on its surface; therefore, it is an ideal system to transport drugs into cells. Long noncoding RNAs (lncRNAs) are a cluster of noncoding RNA longer than 200 nt, which cannot be translated to protein but play an important role in biological and pathophysiological processes. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a highly conserved lncRNA. It was demonstrated that higher MALAT1 levels are related to the poor prognosis of various cancers, including multiple myeloma (MM). We have revealed that MALAT1 regulates DNA repair and cell death in MM; thus, MALAT1 can be considered as a therapeutic target for MM. However, the efficient delivery of the antisense oligo to inhibit/knockdown MALAT1 in vivo is still a problem. In this study, we modify the SWCNT with PEG-2000 and conjugate an anti-MALAT1 oligo to it, test the delivery of this compound in vitro, inject it intravenously into a disseminated MM mouse model, and observe a significant inhibition of MM progression, which indicates that SWCNT is an ideal delivery shuttle for anti-MALAT1 gapmer DNA.

摘要

单壁碳纳米管(SWCNT)是一种新型纳米颗粒,已被用于将多种药物递送至细胞内,如蛋白质、寡核苷酸和合成小分子药物。单壁碳纳米管具有可定制的尺寸、较大的表面积,并且可以通过其表面的不同修饰与药物灵活结合;因此,它是将药物转运到细胞内的理想系统。长链非编码RNA(lncRNA)是一类长度超过200个核苷酸的非编码RNA,其不能翻译为蛋白质,但在生物学和病理生理过程中发挥重要作用。转移相关的肺腺癌转录本1(MALAT1)是一种高度保守的lncRNA。已证明较高的MALAT1水平与包括多发性骨髓瘤(MM)在内的各种癌症的不良预后相关。我们已经揭示MALAT1在MM中调节DNA修复和细胞死亡;因此,MALAT1可被视为MM的治疗靶点。然而,在体内有效递送反义寡核苷酸以抑制/敲低MALAT1仍然是一个问题。在本研究中,我们用聚乙二醇-2000修饰单壁碳纳米管,并将抗MALAT1寡核苷酸与其偶联,在体外测试该化合物的递送,将其静脉注射到播散性MM小鼠模型中,并观察到MM进展受到显著抑制,这表明单壁碳纳米管是抗MALAT1缺口mer DNA的理想递送载体。